Plasma ctDNA enables early detection of temozolomide resistance mutations in glioma.
Jones JJ, Jones KL, Wong SQ, Whittle J, Goode D, Nguyen H, Iaria J, Stylli S, Towner J, Pieters T, Gaillard F, Kaye AH, Drummond KJ, Morokoff AP.
Jones JJ, et al.
Neurooncol Adv. 2024 Mar 19;6(1):vdae041. doi: 10.1093/noajnl/vdae041. eCollection 2024 Jan-Dec.
Neurooncol Adv. 2024.
PMID: 38596716
Free PMC article.